Dawnrays Pharmaceutical Holdings Ltd. (HK:2348) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Dawnrays Pharmaceutical Holdings Ltd. reports a significant increase in profit and earnings per share during the first half of 2024, despite a decrease in revenue and gross profit compared to the same period in 2023. The company’s profit before tax surged by 70.2% and the earnings per share soared by 92.5%, reflecting a robust growth in profitability. The interim dividend per share remains stable at HK$0.015.
For further insights into HK:2348 stock, check out TipRanks’ Stock Analysis page.